112 related articles for article (PubMed ID: 24439676)
21. Morphology of fibrin in disseminated intravascular coagulation (DIC).
Itakura T
Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1115-7. PubMed ID: 286490
[No Abstract] [Full Text] [Related]
22. Significance of a prothrombin assay method using Echis carinatus venom for diagnostic information in disseminated intravascular coagulation syndrome.
Sakuragawa N; Takahashi K; Hoshiyama M; Jimbo C; Matsuoka M; Onishi Y
Thromb Res; 1975 Oct; 7(4):643-53. PubMed ID: 1060188
[No Abstract] [Full Text] [Related]
23. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
24. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
25. [Intravascular disseminated coagulation syndrome in patients with acute leukemias].
Dmoszyńska A
Acta Haematol Pol; 1976; 7(2):139-46. PubMed ID: 1065178
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
27. [Pathogenesis and pathologic physiology of disseminated intravascular coaguration (DIC) in patients with acute promyelocytic leukemia (author's transl)].
Ando Y; Watanabe K
Rinsho Ketsueki; 1976 Apr; 17(4):389-95. PubMed ID: 1066493
[No Abstract] [Full Text] [Related]
28. Tissue factor as a target for the treatment of disseminated intravascular coagulation.
Monteiro RQ
Thromb Res; 2011 Jun; 127(6):495-6. PubMed ID: 21531009
[No Abstract] [Full Text] [Related]
29. One-stage method for assay of tissue factor activity of leukemic cell with special reference to disseminated intravascular coagulation.
Andoh K; Sadakata H; Uchiyama T; Narahara N; Tanaka H; Kobayashi N; Maekawa T
Am J Clin Pathol; 1990 May; 93(5):679-84. PubMed ID: 2327367
[TBL] [Abstract][Full Text] [Related]
30. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
31. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
32. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
[TBL] [Abstract][Full Text] [Related]
33. Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
van den Hengel LG; van Steijn-van Tol AQ; Bertina RM; Versteeg HH; Osanto S
Thromb Res; 2013 Feb; 131(2):187-9. PubMed ID: 23260444
[No Abstract] [Full Text] [Related]
34. Tissue factor-bearing microparticles and thrombus formation.
Zwicker JI; Trenor CC; Furie BC; Furie B
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):728-33. PubMed ID: 21252066
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of microparticles in DIC and its impact on inflammatory processes.
Rahman S; Cichon M; Hoppensteadt D; Cunanan J; Jeske W; Thethi I; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):E202-4. PubMed ID: 21422058
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor in trauma and organ dysfunction.
Gando S
Semin Thromb Hemost; 2006 Feb; 32(1):48-53. PubMed ID: 16479462
[TBL] [Abstract][Full Text] [Related]
37. [Blood coagulation disorders in leukemia].
Pabinger-Fasching I
Wien Med Wochenschr; 1991; 141(9-10):213-6. PubMed ID: 1949847
[TBL] [Abstract][Full Text] [Related]
38. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor.
Nadir Y; Katz T; Sarig G; Hoffman R; Oliven A; Rowe JM; Brenner B
Haematologica; 2005 Nov; 90(11):1549-56. PubMed ID: 16266903
[TBL] [Abstract][Full Text] [Related]
39. [Chronic refractory anemia with manifestations of nocturnal paroxysmal hemoglobinuria and chronic disseminated coagulopathy preceding the onset of acute myelomonocytic leukemia].
Munteanu N; Ursea C
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):89-94. PubMed ID: 2899353
[No Abstract] [Full Text] [Related]
40. Hypercoagulable state and hemorrhage in acute leukemias.
He LZ; Lu LH
Chin Med J (Engl); 1988 Jun; 101(6):448-53. PubMed ID: 3146479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
